PhRMA federal affairs
Executive Summary
Former PhRMA Senior VP-Federal Affairs David Mohler will join the Washington, D.C. offices of law firm Foley Hoag as counsel to the Life Sciences and Government Strategies practices effective April 3. Mohler, who had worked in federal affairs at PhRMA between stints at Upjohn and Merck, returned to PhRMA in 2001 (1"The Pink Sheet" May 14, 2001, p. 36). After resigning on Jan. 3, Mohler was replaced by Alan Gilbert, who joined the association in May 2005 to be groomed for the position. Gilbert, a Capitol Hill veteran, most recently worked in the White House as special assistant to the President for health policy...
You may also be interested in...
PhRMA
David Mohler returns to Pharmaceutical Research & Manufacturers of America as deputy VP-federal affairs. Mohler previously served as a legislative counsel for the association, and was most recently in Merck's D.C. office. Former U.S. Chamber of Commerce health lobbyist Missy Jenkins is joining PhRMA as senior director-federal affairs. Jenkins was previously a staffer to former Rep. Gingrich (R-Ga.) and Sen. Simpson (R-Wyo.). Mohler and Jenkins will report to VP-Federal Affairs & Law Rodger Currie
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.